Case reportMiddle ear adenoma with neuroendocrine differentiation (MEA-ND) in the pediatric population☆
Introduction
Middle ear adenoma with neuroendocrine differentiation (MEA-ND) is a rare tumor that was first reported in 1980. It can be difficult to classify histologically as middle ear adenomas may show purely epithelial (adenoma), purely endocrine (carcinoid) or hybrid differentiation [1]. In spite of this variability, some authors suggest that all middle ear adenomas have elements of neuroendocrine differentiation. Support for this viewpoint comes from immunohistochemical studies with neuroendocrine-specific markers. Torske and Thompson, for example, reviewed 48 middle ear adenomas and demonstrated chromogranin positivity in all, implying some neuroendocrine differentiation despite indistinguishable morphology on routine stains [2].
Historically, MEA-ND has been referred to as a carcinoid tumor, reflecting its histologic similarity to intestinal carcinoids, which are classified by site of origin as foregut, midgut or hindgut lesions [3], [4], [5]. Middle ear carcinoids are associated with the foregut tumors, which generally produce only small amounts of peptide hormones. As a consequence, the typical carcinoid syndrome of cramping, flushing and diarrhea is absent in MEA-ND.
MEA-ND was considered an indolent lesion until 1999 when Mooney et al. [6] reported the first case with metastases. In this paper, we present the youngest case to date of MEA-ND in a 13-year-old boy. We discuss the surgical management of this patient, including findings at the original surgery and on re-exploration one year later. We also review the pathology and differential diagnosis of this tumor.
Section snippets
Case report
A 13-year-old boy followed for chronic otitis media with effusion presented with a left tympanic membrane perforation. His past medical history was significant for ventilation tube placement on several occasions and for recurrent tonsillitis necessitating tonsillectomy at age 11 years.
Examination of the left tympanic membrane was remarkable for a perforation in the attic region and a posterior-superior quadrant white mass. The right tympanic membrane examination was significant only for
Usual presentation
MEA-ND usually presents with hearing loss, as documented by Nyrop et al. in their 1994 review of 30 cases in which nearly all patients had progressive conductive hearing loss. Other complaints on presentation may include tinnitus, aural fulness, otorrhea, and otalgia. Transient facial paresis has also been reported. Age at diagnosis has ranged from 16 to 59 years [7].
On otoscopy, erythema or lateral bulging of an intact tympanic membrane is typical, and at surgery, MEA-ND appears solid and
Conflict of interest
There is no financial or other relationship that might lead to a conflict of interest for any authors.
This study was funded by departmental resources.
Reference (28)
- et al.
Adenoma versus carcinoid tumor of the middle ear: a study of 48 cases and review of the literature
Mod. Pathol.
(2002) - et al.
The classification of carcinoid tumors
Lancet
(1963) - et al.
Carcinoids and carcinoid syndrome
Am. J. Med.
(1987) - et al.
A case of carcinoid tumor of the middle ear producing peptide hormones
Auris Nasus Larynx
(1988) - et al.
Middle ear adenoma. A tumor displaying mucinous and neuroendocrine differentiation
Am. J. Surg. Pathol.
(1989) - et al.
Carcinoid tumor of the middle ear
Am. J. Clin. Pathol.
(1980) - et al.
Middle ear carcinoid: an indolent tumor with metastatic potential
Head Neck
(1999) - et al.
Carcinoid tumor of the middle ear
Ear Nose Throat J.
(1994) - et al.
Epithelial tumors of the middle ear—are middle ear carcinoids really distinct from middle ear adenomas?
Acta Otolaryngol.
(2003) - et al.
Middle ear neoplasms showing adenomatous and neuroendocrine components
J. Laryngol. Otol.
(1989)
Carcinoid tumors of the middle ear
Ann. Otol. Rhinol. Laryngol.
A comparison of paraganglioma, carcinoid tumor, and small-cell carcinoma of the larynx
Arch. Pathol. Lab. Med.
Primary adenocarcinoma of the middle ear
Arch. Otolaryngol.
Differential grading of endolymphatic sac tumor extension by virtue of von Hippel-Lindau disease status
Otol. Neurotol.
Cited by (11)
Management and outcome of middle ear adenomatous neuroendocrine tumours: A systematic review
2021, Oral OncologyCitation Excerpt :After full-text assessment, 65 articles were excluded because of lack of information on treatment or outcome (n = 25), lack of information about individual patients (n = 34) or duplicate cases (n = 6). A total of 111 articles comprising 198 patients with MEANT met the criteria and were included in this systemic review (Figure 1) [2,4-10,14-116]. Clinical characteristics of the included patients are shown in Table 2.
Imaging in Otolaryngology
2018, Imaging in OtolaryngologyDiagnostic Imaging: Head and Neck
2017, Diagnostic Imaging: Head and NeckMiddle Ear Adenoma Imitating Late Postoperative Complication
2021, Ear, Nose and Throat JournalMiddle ear neuroendocrine tumor: A case report and review of the literature in pediatric population
2021, Journal of International Advanced OtologyPathology of malignant neoplasms of the ear and temporal bone
2018, Temporal Bone Cancer
- ☆
This work was originally presented at the meeting of the American Society of Pediatric Otolaryngology at COSM, Chicago, IL, May 20–22, 2006.